10/14/2026
A new study, published in Scientific Reports and authored by Stanley Rockson and PhD candidate Catharine Bowman, describes the results of a clinical trial testing the experimental oral medication acebilustat in study volunteers with lymphedema of the lower limbs. The results indicate the drug effectively alleviated many of the condition's most burdensome symptoms.
Lymphedema affects roughly 10 million people in the U.S. and occurs when excess lymph fluid builds up in the arms and legs instead of draining through the lymphatic system into the bloodstream. Rockson describes it as a common but underappreciated condition, and there is currently no approved medication to treat it.
Read more: https://stan.md/3WhqOS1